Skip to main content
Barton Haynes, MD, Allergy & Immunology, Durham, NC

BartonHaynesMD

Allergy & Immunology Durham, NC

Professor, Medicine, Duke University School of Medicine

Dr. Haynes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Haynes' full profile

Already have an account?

  • Office

    2100 Erwin Rd
    Durham, NC 27705
    Phone+1 919-620-4467

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1973 - 1975
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1973

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1980 - 2025
  • TX State Medical License
    TX State Medical License 1973 - 2012
  • Allergy & Immunology
    American Board of Allergy and Immunology Allergy & Immunology
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Clinical & Laboratory Immunology
    American Board of Internal Medicine Clinical & Laboratory Immunology
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 1997
  • Elected Member The American Society for Clinical Investigation, 1983
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Publications & Presentations

PubMed

Press Mentions

  • How Broadly Neutralizing Antibodies Are Driving Next-Gen Vaccines
    How Broadly Neutralizing Antibodies Are Driving Next-Gen VaccinesJanuary 23rd, 2025
  • Broadly Neutralizing Antibodies: The Key to Next-Generation Vaccine Breakthroughs
    Broadly Neutralizing Antibodies: The Key to Next-Generation Vaccine BreakthroughsJanuary 23rd, 2025
  • In a 1st, HIV Vaccine Triggers Rare and Elusive Antibodies in Human Patients
    In a 1st, HIV Vaccine Triggers Rare and Elusive Antibodies in Human PatientsMay 21st, 2024
  • Join now to see all